IP Group Plc IPZYF
0.91 USD 0.00 (+0.00%)
At closeNov 2, 2026, 4:00 PM EST
0.87 Day range 0.88
0.6781 52-week range 0.9054
- YTD
- +14.61%
- 1 year
- +33.52%
News
proactiveinvestors.com IP Group cheers investor interest in spin-outs, calls for more supportive Govt backing UK university spinouts attracted £1.56 billion of investment in the first half of 2026, but funding for new ventures collapsed by more than two-thirds, according to research published by IP Group PLC…
proactiveinvestors.com IP Group leads funding round for University of Liverpool AI spin-out Matter Machine IP Group PLC (LSE:IPO) has led a £4 million funding round in Matter Machine, a University of Liverpool spin-out using artificial intelligence to accelerate the discovery of new materials. The…
proactiveinvestors.com IP Group banks £21m in Oxford Nanopore divestment IP Group PLC (LSE:IPO) told investors it has banked around £21 million from a partial sale of its stake in Oxford Nanopore Technologies PLC (LSE:ONT) while retaining a holding worth more than £150…
seekingalpha.com IP Group Plc (IPZYF) Q2 2026 Earnings Call Transcript IP Group Plc (IPZYF) Q2 2026 Earnings Call Transcript
marketbeat.com IP Group H1 Earnings Call Highlights IP Group LON: IPO reported higher net asset value, strong cash realizations and broad portfolio activity in the first half of 2026, while management said it remains focused on converting portfolio…
reuters.com Top investor Railpen walks away from UK's IP Group Railpen, the largest shareholder in Britain's IP Group , said on Monday that it does not intend to make another offer for the early-stage science investor as the companies could not agree on a…
proactiveinvestors.co.uk Frontier IP Group: Cambridge Raman Imaging secures €400,000 European grant Frontier IP Group PLC (LSE:FIPP, FRA:8WT) said its portfolio company Cambridge Raman Imaging has secured a €400,000 European grant as it targets pharmaceutical manufacturing quality control and…
proactiveinvestors.co.uk IP Group board may struggle to back sweetened Railpen offer, says Deutsche Bank The board of IP Group PLC (LSE:IPO), the London-listed technology investor, may struggle to recommend an improved takeover proposal from pension fund Railpen without further concessions, according to…
businesswire.com Mach42 Completes £7M Funding Round, Led by IP Group With Investment From BGF and Foresight Group SANTA CLARA, Calif. & OXFORD, England--(BUSINESS WIRE)-- #Mach42--Mach42 completes £7m funding round, led by IP Group with investment from BGF and Foresight Group.
reuters.com UK's IP Group rebuffs Railpen's revised 71.3 pence proposal IP Group's board of directors on Monday unanimously rejected a sweetened 71.3 pence-per-share takeover proposal from its largest shareholder, Railpen, citing significant undervaluation of the…
proactiveinvestors.co.uk Railpen lifts IP Group offer with cash, Nanopore stake and Metsera upside Railpen has raised its takeover proposal for IP Group PLC (LSE:IPO), offering shareholders a mix of cash, shares in Oxford Nanopore and a contingent payout linked to the biotech firm Metsera. The…
reuters.com UK's IP Group gets sweetened takeover offer from top investor Railpen Railpen, the largest shareholder in Britain's IP Group , said on Friday it has made a sweetened takeover offer for the early-stage science investor, nearly a month after IP Group rejected an…
proactiveinvestors.co.uk IP Group rejects Railpen takeover proposal as too low IP Group PLC (LSE:IPO), the company that backs spin-out businesses, has rejected a takeover proposal from one of its largest shareholders, the railways pension scheme Railpen. The board said the…
proactiveinvestors.co.uk Deutsche Bank unsurprised by IP Group's rejection of Railpen approach Deutsche Bank has said it is 'unsurprised' that IP Group PLC (LSE:IPO) rejected a take-private approach from Railpen, its largest shareholder. The bank, whose analyst Kane Slutzkin rates the stock a…
proactiveinvestors.co.uk IP Group rejects takeover approach from its biggest shareholder IP Group PLC (LSE:IPO), the London-listed investor that backs science and technology start-ups, has rejected a £616 million takeover approach from its largest shareholder. The approach came from…
proactiveinvestors.co.uk IP Group's Istesso starts phase II trial of leramistat in sarcopenia IP Group PLC (LSE:IPO), the FTSE 250 investment company focused on science and technology businesses, has announced that portfolio company Istesso has begun dosing patients in a phase II trial of its…
proactiveinvestors.co.uk IP Group portfolio company Enterprise Therapeutics reports positive phase II results in cystic fibrosis IP Group PLC (LSE:IPO), the London-listed science and technology investor, has flagged positive phase II trial results from portfolio company Enterprise Therapeutics for ETD001, its lead candidate…
proactiveinvestors.co.uk IP Group portfolio company Enterprise Therapeutics reveals positive cystic fibrosis trial results IP Group PLC (LSE:IPO) told investors that its portfolio company Enterprise Therapeutics has reported positive Phase 2 trial results for ETD001, its lead candidate for cystic fibrosis, after the…
proactiveinvestors.co.uk IP Group appoints former 3i chief as incoming chair IP Group PLC (LSE:IPO), the LSE-listed science and technology investor, has appointed Michael Queen as non-executive director and chair designate, concluding a succession process announced last year.…
proactiveinvestors.co.uk IP Group investee company First Light Fusion raises £25m in fusion energy push First Light Fusion, an IP Group PLC (LSE:IPO) portfolio company developing inertial fusion energy technology, has raised £25 million in the first close of a new funding round led by specialist fusion…